Solution allows a cardiologist to perform coronary angioplasties using an integrated control command unit Solution allows a cardiologist to perform coronary angioplasties using an integrated control ...

Rouen, France – Robocath, a company that designs, develops and commercializes cardiovascular robotic platforms for the treatment of vascular diseases, today announces the successful completion of ...

Rouen, France – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its ...

Rouen, France, November 2, 2020 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces creation of the ...

100% clinical success rate: zero complications linked to robot up to 30 days post-procedure >95% technical success rate 84.5% average reduction in physician radiation exposure The results will be ...

Robocath SAS said Cathbot, its joint venture set up in 2020, has enrolled the final patient for its clinical study in China to evaluate the safety and the efficacy of its robotic platform for ...

A European study of 62 patients showed that coronary angioplasties using the R-One robot from Robocath are safe and effective, and reduce physicians' exposure to radiation. The R-Evolution trial was a ...

(MENAFN- Andrew Lloyd & Associates) Rouen, France, May 15, 2024 – Robocath, a company that designs, develops and markets innovative robotic solutions to treat cardiovascular and neurovascular diseases ...

(MENAFN- Andrew Lloyd & Associates) Rouen, France, November 24, 2021 – Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases ...

Rouen, France-based Robocath, a medical robotics start-up specialising in endovascular procedures, has formerly appointed Pascal Guy as its new chief executive officer. Guy first joined Robocath in ...

Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces it has successfully completed its first robotic ...